Results 181 to 190 of about 3,997,149 (388)

The Impact of Non-Adherence to Antihypertensive Drug Therapy. [PDF]

Healthcare (Basel), 2023
Gardezi SKM, Aitken WW, Jilani MH.
europepmc   +1 more source

Long‐term remission in gout: Challenges and future opportunities

Rheumatology &Autoimmunity, EarlyView.
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley   +1 more source

Antihypertensive drugs utilisation and educational activities [PDF]

, 2010
Radmila Veličković-Radovanović, Jasmina Petrović, B Kodela, Slobodan Јаnkovic   +3 more
openalex   +1 more source

Prescription Patterns for the Use of Antihypertensive Drugs for Primary Prevention Among Patients With Hypertension in the United Kingdom [PDF]

, 2021
Tianze Jiao, Robert W. Platt, Antonios Douros, Kristian B. Filion   +3 more
openalex   +1 more source

Resistant hypertension and renal denervation: Who's kidding whom? [PDF]

, 2014
Sever, P
core   +1 more source

Hepatic fibrosis in patients diagnosed with rheumatoid arthritis and psoriatic arthritis receiving methotrexate: A cross‐sectional analysis using transient elastography

Rheumatology &Autoimmunity, EarlyView.
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Kanon Jatuworapruk   +3 more
wiley   +1 more source

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Journal of the American Medical Association (JAMA), 2002
J. Wright, G. Bakris, T. Greene, L. Agodoa, L. Appel, J. Charleston, D. Cheek, Janice E G Douglas-Baltimore, J. Gassman, R. Glassock, L. Hebert, K. Jamerson, J. Lewis, R. Phillips, R. Toto, J. Middleton, S. Rostand   +16 more
semanticscholar   +1 more source

Impact of barometric pressure on blood pressure during dialysis: Introducing intradialytic time‐averaged cumulative systolic blood pressure (TACsBP‐inD) as a new metric

Therapeutic Apheresis and Dialysis, Volume 29, Issue 3, Page 525-534, June 2025.
Abstract Background Blood pressure is a crucial risk factor for hemodialysis patients, but the specific impact of weather factors, particularly barometric pressure, on blood pressure remains unclear. This study aims to examine the relationship between barometric pressure and blood pressure in hemodialysis patients. Methods We conducted a single‐center,
Kosaku Iwatsubo, Shouichi Fujimoto, Michikazu Nakai   +2 more
wiley   +1 more source

An improved synthesis of Telmisartan: an antihypertensive drug

, 2009
A. Sanjeev Kumar, Samir Ghosh, R. Soundararajan, G. N. Mehta   +3 more
openalex   +2 more sources

Understanding the Oral Health Status and Factors Affecting Poor Oral Health in People Living With Severe Mental Illness: A Cross‐Sectional Study

Australian Dental Journal, EarlyView.
ABSTRACT Objectives To assess the oral health status of patients with severe mental illness visiting the Collaborative Centre for Cardiometabolic Health in Psychosis clinics and examine the effect of demographic, medical and social factors on Oral Health (OH). Methods The cross‐sectional study included adults aged 18–65 years with severe mental illness
Shilpi Ajwani, Premala Sureshkumar, Sameer Bhole, Tim Lambert   +3 more
wiley   +1 more source